Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy.
A 3-month-old boy presented with a 2-week history of rapidly spreading skin rashes. Physical examination revealed generalized urticarial plaques with tense bullae and small vesicles. Histologic examination and immunofluorescence established the diagnosis of bullous pemphigoid. The disease was resistant to conventional therapies with the combination of corticosteroids, dapsone, and erythromycin. Finally, intravenous immunoglobulin therapy brought about a remarkable improvement. We suggest that intravenous immunoglobulin therapy is a valuable treatment option for intractable bullous pemphigoid in infants as well as in adults.
Sugawara
Nobuyuki
N
Department of Dermatology, Gunma University Graduate School of Medicine, Gunma, Japan. nsuga@showa.gunma-u.ac.jp
Nagai
Yayoi
Y
Matsushima
Yoichiro
Y
Aoyama
Kumi
K
Ishikawa
Osamu
O
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D010391:Pemphigoid, Bullous / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous